OBM Geriatrics is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Read more
Publication Speed (median values for papers published in 2024): Submission to First Decision: 6.3 weeks; Submission to Acceptance: 11.4 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
A Proactive Approach to Sarcopenia in Aging Populations
Submission Deadline:
September 30, 2025 (Open)
Submit Now
Guest Editor
Daniel A. Traylor,
PhD
Department of Exercise Science & Athletic Training, Adrian College, Adrian, MI, USA
Website | E-Mail
Research Interests: Strength & conditioning; exercise science; muscle; skeletal muscle physiology; muscle physiology
About This Topic
As we age, our bodies often exhibit a decline in muscle mass and strength, a condition known scientifically as 'sarcopenia.' This age-related ailment is common in elderly individuals and is linked to a higher probability of incidents such as falls and fractures, an uptick in disease prevalence and mortality, and a greater dependency on assisted living arrangements. However, the adverse impacts of sarcopenia can be curbed, and even circumvented, through a comprehensive strategy that includes resistance training, consistent physical activities, daily optimal protein consumption, and tailored nutritional interventions. In the battle against sarcopenia, a combination of strength training and regular exercise plays a vital role. Coupled with a diet that ensures an ideal daily dose of protein, it forms a strong defense against muscle degradation. Additionally, specific nutritional interventions, including the intake of critical nutrients such as amino acids, vitamin D, calcium, and leucine, have been shown to provide significant benefits. In conclusion, aging is inevitable, but conditions like sarcopenia can be managed effectively through a synergistic exercise approach, a protein-rich diet, and targeted nutritional measures.
Keywords
Aging; sarcopenia; strength training; muscle deterioration; dynapenia; physical activity; protein intake; amino acids; vitamin D; calcium; leucine
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (geriatrics@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
Publication
Open Access
Concept Paper
Abstract
Elderly patients with ovarian and pancreatic cancer frequently experience malnutrition and sarcopenia, which negatively impact treatment tolerance, functional outcomes, and survival. The increasing use of neoadjuvant chemotherapy in this population necessitates structured interventions to mitigate these challenges. While prehabilitation has [...]
|
Jasmin Hundal
and